ID KTC-2 AC CVCL_6476 SY KTC2 DR cancercelllines; CVCL_6476 DR Cosmic; 1239964 DR Cosmic; 2054080 DR Wikidata; Q54900621 RX CelloPub=CLPUB00144; RX PubMed=12729473; RX PubMed=18713817; RX PubMed=23833040; RX PubMed=25675381; RX PubMed=30737244; CC Population: Japanese. CC Doubling time: 36 +- 3 hours (PubMed=12729473). CC Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244). CC Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu490Ter (c.1468G>T); Zygosity=Heterozygous (PubMed=30737244). CC Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244). CC Omics: Transcriptomics; Microarray. CC Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. ST Source(s): PubMed=18713817; PubMed=30737244 ST Amelogenin: X ST CSF1PO: 12,13 ST D13S317: 8,12 ST D16S539: 10,11 ST D18S51: 16 ST D21S11: 30 ST D3S1358: 15 ST D5S818: 12 ST D7S820: 11 ST D8S1179: 12 ST FGA: 23 ST TH01: 6 ST TPOX: 8 ST vWA: 17,18 DI NCIt; C3878; Thyroid gland anaplastic carcinoma DI ORDO; Orphanet_142; Anaplastic thyroid carcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female AG 70Y CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 21 // RX CelloPub=CLPUB00144; RA Kurebayashi, Junichi RA Tanaka, Katsuhiro RA Yamamoto, Yutaka RA Okubo, Sumiko RA Sonoo, Hiroshi RT "Human epidermal growth factor receptor 1 and thrombospondin-1 in RT thyroid cancer."; RL (In book chapter) Trends in thyroid cancer research. Horizons in cancer research, Vol. 37; Milton, Carl A. (eds.); pp.89-116; Nova Science Publishers; Hauppauge; USA (2007). // RX PubMed=18713817; DOI=10.1210/jc.2008-1102; PMCID=PMC2582569; RA Schweppe, Rebecca E. RA Klopper, Joshua Paul RA Korch, Christopher T. RA Pugazhenthi, Umarani RA Benezra, Miriam RA Knauf, Jeffrey A. RA Fagin, James Alexander RA Marlow, Laura A. RA Copland, John Alton 3rd RA Smallridge, Robert Christian RA Haugen, Bryan R. RT "Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer RT cell lines reveals cross-contamination resulting in cell line RT redundancy and misidentification."; RL J. Clin. Endocrinol. Metab. 93:4331-4341(2008). // RX PubMed=12729473; DOI=10.1089/105072503321582042; RA Kurebayashi, Junichi RA Otsuki, Takemi RA Tanaka, Katsuhiro RA Yamamoto, Yutaka RA Moriya, Takuya RA Sonoo, Hiroshi RT "Medroxyprogesterone acetate decreases secretion of interleukin-6 and RT parathyroid hormone-related protein in a new anaplastic thyroid cancer RT cell line, KTC-2."; RL Thyroid 13:249-258(2003). // RX PubMed=23833040; DOI=10.1210/jc.2013-2383; PMCID=PMC3763971; RA Landa, Inigo RA Ganly, Ian RA Chan, Timothy A. RA Mitsutake, Norisato RA Matsuse, Michiko RA Ibrahimpasic, Tihana RA Ghossein, Ronald A. RA Fagin, James Alexander RT "Frequent somatic TERT promoter mutations in thyroid cancer: higher RT prevalence in advanced forms of the disease."; RL J. Clin. Endocrinol. Metab. 98:E1562-E1566(2013). // RX PubMed=30737244; DOI=10.1158/1078-0432.CCR-18-2953; PMCID=PMC6522280; RA Landa, Inigo RA Pozdeyev, Nikita RA Korch, Christopher T. RA Marlow, Laura A. RA Smallridge, Robert Christian RA Copland, John Alton 3rd RA Henderson, Ying C. RA Lai, Stephen Y. RA Clayman, Gary L. RA Onoda, Naoyoshi RA Tan, Aik-Choon RA Garcia-Rendueles, Maria E.R. RA Knauf, Jeffrey A. RA Haugen, Bryan R. RA Fagin, James Alexander RA Schweppe, Rebecca E. RT "Comprehensive genetic characterization of human thyroid cancer cell RT lines: a validated panel for preclinical studies."; RL Clin. Cancer Res. 25:3141-3151(2019). // RX PubMed=25675381; DOI=10.1210/jc.2014-2764; PMCID=PMC4422887; RA von Roemeling, Christina A. RA Marlow, Laura A. RA Pinkerton, Anthony B. RA Crist, Angela RA Miller, James RA Tun, Han W. RA Smallridge, Robert Christian RA Copland, John Alton 3rd RT "Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals RT stearoyl CoA desaturase 1 as a novel therapeutic target."; RL J. Clin. Endocrinol. Metab. 100:E697-E709(2015). //